1-1 of 1
Mary Agajanian
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

EPHB4 is a therapeutic target in AML and promotes leukemia cell survival via AKT

Akil A. Merchant, Aparna Jorapur, Amy McManus, Ren Liu, Valery Krasnoperov, Parvesh Chaudhry, Mohan Singh, Lisa Harton, Mary Agajanian, Miriam Kim, Timothy J. Triche, Jr, Brian J. Druker, Jeffrey W. Tyner, Parkash S. Gill
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1635–1644.
https://doi.org/10.1182/bloodadvances.2017005694
Published: 2017
Includes: Supplemental data